HighTower Advisors, LLC - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 319 filers reported holding IMMUNOMEDICS INC in Q2 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$504,000
+142.3%
5,930
+1.0%
0.00%
+100.0%
Q2 2020$208,000
-62.5%
5,871
-85.8%
0.00%
-75.0%
Q1 2020$554,000
-37.1%
41,207
-1.3%
0.00%
-20.0%
Q4 2019$881,000
+63.8%
41,729
+3.3%
0.01%
+66.7%
Q3 2019$538,000
-7.7%
40,386
-4.0%
0.00%0.0%
Q2 2019$583,000
-29.2%
42,048
-1.8%
0.00%
-40.0%
Q1 2019$823,000
+23.4%
42,830
-8.3%
0.01%0.0%
Q4 2018$667,000
-30.8%
46,730
+0.7%
0.01%
-28.6%
Q3 2018$964,000
-8.5%
46,423
+4.2%
0.01%
-12.5%
Q2 2018$1,054,000
+33.4%
44,549
-17.7%
0.01%
+14.3%
Q1 2018$790,000
-6.0%
54,150
+4.4%
0.01%0.0%
Q4 2017$840,000
+15.5%
51,865
+0.1%
0.01%
+16.7%
Q3 2017$727,000
+55.0%
51,815
-2.3%
0.01%
+50.0%
Q2 2017$469,000
+25.1%
53,060
-8.7%
0.00%0.0%
Q1 2017$375,000
+100.5%
58,115
+13.8%
0.00%
+100.0%
Q4 2016$187,000
+3.9%
51,065
-6.2%
0.00%0.0%
Q3 2016$180,000
+41.7%
54,465
+1.1%
0.00%0.0%
Q2 2016$127,000
-17.0%
53,865
-10.7%
0.00%
Q1 2016$153,000
-16.8%
60,3150.0%0.00%
-100.0%
Q4 2015$184,000
+76.9%
60,315
+0.6%
0.00%
+100.0%
Q3 2015$104,000
-49.5%
59,965
+18.1%
0.00%
-66.7%
Q2 2015$206,00050,7650.00%
Other shareholders
IMMUNOMEDICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 4,750,000$112,433,00020.02%
Avoro Capital Advisors LLC 17,714,461$419,301,00016.14%
Foresite Capital Management III, LLC 2,541,729$60,163,00012.96%
Foresite Capital Management IV, LLC 1,231,543$29,151,0009.94%
Ghost Tree Capital, LLC 1,250,000$29,588,0008.71%
NEXTHERA CAPITAL LP 1,329,104$31,460,0004.87%
RA Capital Management 3,119,778$73,845,0004.79%
DLD Asset Management, LP 2,682,100$63,458,0004.78%
Palo Alto Investors LP 4,803,364$113,696,0004.54%
DLD Asset Management, LP 2,411,600$57,058,0004.30%
View complete list of IMMUNOMEDICS INC shareholders